John Bencich

CIK 1477056 · CHIEF FINANCIAL OFFICER · last filed 2026-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.10M

Companies

4

Total Filings

38

Lifetime Open-Market Net

$109.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AEON CHIEF FINANCIAL OFFICER 754,717 $0.72 $539.7K $0 1 2026-04-03
ACHV CEO 100,636 $5.52 $555.5K $115.3K 27 2024-08-20
ACHIEVE LIFE SCIENCES, INC. (OGXI) Delisted CFO 1,053 -$5.4K 8 2017-08-03
Trubion Pharmaceuticals, Inc (TRBN) Delisted V.P. and CFO 0 $0 2 2010-10-28

Recent Filings · Page 2 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-11-21 ACHV Buy (P) +22,000 $0 EDGAR
2022-08-18 ACHV Grant (A) +3,059 $13.4K EDGAR
2022-04-29 ACHV Mixed +5,673 -$13.6K EDGAR
2022-01-05 ACHV Grant (A) $0 EDGAR
2021-08-19 ACHV Mixed +47 -$143 EDGAR
2021-05-27 ACHV Buy (P) +6,000 $42.0K EDGAR
2021-01-28 ACHV Grant (A) $0 EDGAR
2020-11-18 ACHV Grant (A) $0 EDGAR
2020-08-19 ACHV Mixed +36 -$295 EDGAR
2020-01-30 ACHV Grant (A) $0 EDGAR
Showing 1120 of 38
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.